X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (18) 18
female (9) 9
humans (9) 9
index medicus (9) 9
middle aged (8) 8
aged (6) 6
performing operations (6) 6
transporting (6) 6
breast neoplasms - drug therapy (5) 5
quality of life (5) 5
adult (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
chemical surface treatment (4) 4
chemistry (4) 4
chemotherapy (4) 4
cleaning (4) 4
cleaning in general (4) 4
cleaning or degreasing of metallic material by chemicalmethods other than electrolysis (4) 4
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (4) 4
coating material with metallic material (4) 4
coating metallic material (4) 4
diffusion treatment of metallic material (4) 4
further section · weitere sektionen (4) 4
inhibiting corrosion of metallic material or incrustation ingeneral (4) 4
male (4) 4
metallurgy (4) 4
prevention of fouling in general (4) 4
angiogenesis inhibitors - therapeutic use (3) 3
antineoplastic agents, hormonal - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
bevacizumab (3) 3
breast cancer (3) 3
cancer (3) 3
cardiac & cardiovascular systems (3) 3
disease-free survival (3) 3
prospective studies (3) 3
quality-of-life (3) 3
survival (3) 3
tamoxifen (3) 3
therapy (3) 3
treatment outcome (3) 3
trial (3) 3
women (3) 3
anastrozole (2) 2
animals (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
assessment (2) 2
association (2) 2
brain neoplasms - drug therapy (2) 2
breast neoplasms - metabolism (2) 2
carcinoma (2) 2
cell biology (2) 2
children and adolescents (2) 2
clinical study (2) 2
disease progression (2) 2
follow-up studies (2) 2
glioblastoma - drug therapy (2) 2
inflammation (2) 2
kaplan-meier estimate (2) 2
medicine, general & internal (2) 2
mice, knockout (2) 2
neoplasm metastasis (2) 2
pilot projects (2) 2
pilot study (2) 2
questionnaire (2) 2
randomized-trial (2) 2
rating scales (2) 2
tamoxifen - administration & dosage (2) 2
time factors (2) 2
accessories, closures, or fittings therefor (1) 1
activation (1) 1
active transport, cell nucleus (1) 1
adaptation, psychological (1) 1
adhesion (1) 1
adjuvant treatment (1) 1
adolescent (1) 1
adults (1) 1
advanced breast cancer (1) 1
aminoglutethimide - administration & dosage (1) 1
aminoglutethimide - adverse effects (1) 1
analysis (1) 1
anastrozol (1) 1
anemia - chemically induced (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - adverse effects (1) 1
antagonist drugs (1) 1
anthracyclines (1) 1
anti-angiogenic (1) 1
antiangiogenic pretreatment (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 02/2015, Volume 26, Issue 2, pp. 313 - 320
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 5548 - 11
Whether 2nd-line-chemotherapy (2LCTX) + best-supportive-care (BSC) benefits patients with advanced biliary tract cancer (aBTC) more than BSC alone is unclear.... 
SURVIVAL | MULTICENTER | THERAPY | CISPLATIN | MULTIDISCIPLINARY SCIENCES | COHORT | PLATINUM COMBINATION | FAILURE | ASSOCIATION | GEMCITABINE | Biliary tract | Chemotherapy | Patients | Metastases | Cancer
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2013, Volume 108, Issue 7, pp. 1408 - 1414
Journal Article
by Kobayashi, J and Yoshida, M and Tarui, S and Hirata, M and Takahashi, K and Naruse, K and Kasahara, S and Sano, S and Oh, H and Halbach, M and Peinkofer, G and Baumgartner, S and Krausgrill, B and Fatima, A and Hescheler, J and Saric, T and Mueller-Ehmsen, J and Kamakura, T and Makiyama, T and Sasaki, K and Hattori, T and Ohno, S and Yoshida, Y and Horie, M and Kimura, T and Guan, K and Streckfuss-Boemeke, K and Wolf, F and Azizian, A and Stauske, M and Tiburcy, M and Wagner, S and Maier, L. S and Zimmermann, W. H and Hasenfuss, G and Mehta, A and Sequiera, G. L and Sudibyo, Y and Jun, L and Wong, P and Liew, R and Shim, W and Dambrot, C and Braam, S. R and Freund, C. M. A. H and Van De Pas, S and Ward-Van Oostwaard, D and Atsma, D. E and Mummery, C. L and Shigeta, T and Kureishi Bando, Y and Aoyama, M and Monji, A and Mitsui, T and Cheng, X. W and Murohara, T and Saikawa, T and Nishio, S and Takahashi, N and Thuc, L. C and Saito, S and Fukui, A and Kume, O and Hara, M and Nakagawa, M and Teshima, Y and Radovits, T and Olah, A and Nemeth, B and Hidi, L and Birtalan, E and Kokeny, G and Szabo, G and Merkely, B and Rottlaender, D and Wolny, M and Motloch, L. J and Gebing, T and Reda, S and Hoppe, U. C and Feijoo-Bandin, S and Rodriguez-Penas, D and Garcia-Rua, V and Otero, M. F and Mosquera-Leal, A and Gonzalez-Juanatey, J. R and Lago, M. F and Dimitriadis, K and Tsioufis, C and Tsiachris, D and Kasiakogias, A and Psaltopoulou, T and Tzamou, V and Mazaraki, A and Andrikou, I and Pitsavos, C and Stefanadis, C and Mill, J. G and Rodrigues, S. L and Baldo, M. P and ... and on behalf of IRTG - 1566 PROMISE and on behalf of The SAVIOR investigators and on behalf of On behalf of the PLATelet inhibition and patient Outcomes (PLATO) investigators and on behalf of EPES Acute Cardiac Care group and on behalf of WHICH? Trial Investigators and on behalf of Prof. Geibel. PD Dr. Harloff, Dr. Guenther and on behalf of Italian ClinicalService Project and on behalf of PL-ACS Invaestigators and on behalf of EmbraceAC Study Group and on behalf of CHFN and on behalf of The interventional working group of the lebanese society of cardiology and on behalf of SAFETY Investigators and on behalf of grant of IGA Ministry of health of the Czech Republic no. NS9824-4/2008 and on behalf of the Korean Hypertension Research Network and on behalf of Jian-Jun Li and on behalf of the FRANCE2 steering Committee and on behalf of Cardiology&Development and on behalf of St. Antonius center for platelet function research and on behalf of the MANTRA Study investigators and on behalf of ROCKET AF Executive Committee and on behalf of Tako tsubo Italian Network and on behalf of the AF meta-analysis team and on behalf of Ibaraki Coronary Artery Disease Study (ICAS) registry and on behalf of ICALOR and on behalf of MANTRA Study Investigators and on behalf of Competence Network Heart Failure Germany and on behalf of APPRAISE-2 Study Group and on behalf of Sapaldia Study Group and on behalf of CHF-HOT Study and on behalf of CAPIRE Investigators and on behalf of Francesco Barilla, et al and on behalf of VIDA-IC investigators and on behalf of The BETTER-CARE Study Investigators and on behalf of BMIR and on behalf of The International Registry of Acute Aortic Dissection (IRAD) and on behalf of Francesca Frexia and on behalf of VIDA IC investigators and on behalf of FAST-MI 2010 and on behalf of Hypersleep and on behalf of ACTION and on behalf of SHIFT echostudy and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of Barbanza investigators and on behalf of The GARFIELD Investigators and on behalf of the CHOICE trial investigators and on behalf of NIPPON DATA80/90 Research Group and on behalf of MINAP Steering Group and on behalf of PROTECT investigators and on behalf of TuePic and on behalf of Center for Clinical Heart Research, Oslo University Hospital, Ullevaal and on behalf of PROTECTION IV investigators and on behalf of ASAP Investigators and on behalf of FP7 project and on behalf of GARFIELD Investigators and on behalf of LIPID study investigators and on behalf of NIPPON DATA 80 Research Group and on behalf of COACH and on behalf of INH and on behalf of CARDIO-ARSIF registry and on behalf of Hopital Cardiologique, CIC a thematique cardiovasculaire CIC-005 INSERM, Universite Victor Segalen, CHU de Bordeaux, Bordeaux, France and on behalf of Registry of Cardiovascular Interventions, Czech Republic and on behalf of INPETU and on behalf of The International Registry of Acute Aortic Dissection and on behalf of the FAST-MI 2010 investigators and on behalf of PL-ACS Invastigators and on behalf of The Austrian Acute PCI Investigators and on behalf of Competence Network Heart Failure and on behalf of Thyroid Studies Collaboration and on behalf of University Centre for Cardiovascular Science and on behalf of SCAAR-registry and on behalf of BASKET/BASKET-PROVE Investigators and on behalf of Cardiac and on behalf of on behalf of the German Competence Network Heart Failure and the German Competence Network for HIV/AIDS and on behalf of Northern Iwate Heart Disease Registry Consortium and on behalf of J-MELODIC Investigators and on behalf of nil and on behalf of German Competence Network Heart Failure and on behalf of ARISTOTLE Investigators and on behalf of NA and on behalf of Popovici M
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 19 - 338
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e15084 - e15084
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e15621 - e15621
Conference Proceeding
Neuro-Oncology, ISSN 1522-8517, 2014, Volume 16, Issue 1, pp. 92 - 102
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 56, pp. 96048 - 96061
Introduction: Inflammatory biomarkers are useful prognostic tools in cancer patients. However, the prognostic and predictive value of inflammatory biomarkers... 
Biomarker | Inflammation | Metastatic | Colorectal cancer | Palliative chemotherapy | SURVIVAL | LYMPHOCYTE RATIO | colorectal cancer | NEUTROPHIL | metastatic | inflammation | palliative chemotherapy | biomarker | MONOCYTE RATIO | CHEMOTHERAPY | CELL BIOLOGY
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2009, Volume 35, Issue 10, pp. 1048 - 1054
Abstract Purpose To evaluate the triplet combination of bevacizumab, capecitabine and docetaxel (XTA) as neoadjuvant therapy for breast cancer. Experimental... 
Hematology, Oncology and Palliative Medicine | Surgery | Neoadjuvant | Targeted | Breast cancer | Preoperative | Anti-angiogenic | Bevacizumab | SURVIVAL | SURGERY | CYCLOPHOSPHAMIDE | DOXORUBICIN | RECEPTOR | PRIMARY CHEMOTHERAPY | TRIAL | PLUS DOCETAXEL | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | HER2 | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Drug-Related Side Effects and Adverse Reactions | Adult | Deoxycytidine - adverse effects | Female | Neoadjuvant Therapy | Angiogenesis Inhibitors - adverse effects | Taxoids - adverse effects | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | Pilot Projects | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Analysis | Oncology, Experimental | Research | Antineoplastic agents | Cancer | Index Medicus
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2013, Volume 108, Issue 7, pp. 1408 - 1414
Background: There exists evidence that body mass index (BMI) impacts on the efficacy of aromatase inhibitors in patients with breast cancer. The relationship... 
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 2018, Volume 41, pp. 248 - 248
Conference Proceeding
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, ISSN 0028-1298, 02/2018, Volume 391, pp. S39 - S39
Conference Proceeding
Cardiovascular Research, ISSN 0008-6363, 06/2015, Volume 106, Issue 3, pp. 398 - 407
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 2018, Volume 41, pp. 224 - 224
Conference Proceeding
Oncology, ISSN 0030-2414, 06/2011, Volume 80, Issue 1-2, pp. 34 - 41
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.